CorMedix Inc. Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update
August 12, 2021 16:01 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Aug. 12, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. to Report Second Quarter 2021 Financial Results and Provide a Corporate Update on August 12
July 28, 2021 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., July 28, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. Completes Sale of $1.3 Million of NOL Tax Benefits Through The New Jersey Economic Development Authority Program
June 10, 2021 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., June 10, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. to Participate in Fireside Chat at the JMP Securities Life Sciences Conference
June 09, 2021 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., June 09, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. to Present at the Jefferies Virtual Healthcare Conference
May 27, 2021 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., May 27, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. Reports First Quarter 2021 Financial Results and Provides Business Update
May 13, 2021 16:01 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. Announces Appointment of Chief Commercial Officer
May 13, 2021 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. to Report First Quarter 2021 Financial Results and Provide a Corporate Update on May 13
May 05, 2021 08:00 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., May 05, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. to Participate at the 7th Annual Truist Securities Life Sciences Summit
April 28, 2021 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., April 28, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Has Meeting With FDA on DefenCath Catheter Lock Solution NDA
April 14, 2021 09:00 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., April 14, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...